☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Grünenthal
Grünenthal Signed Joint Venture Collaboration Agreement with Kyowa Kirin to Establish Medicines Portfolio
November 25, 2022
Grünenthal Entered into a License Agreement with Shionogi for Resiniferatoxin (RTX) to Treat Pain Associated with Knee Osteoarthri...
August 5, 2022
Grünenthal Entered into an Agreement with Bayer to Acquire Nebido for Male Hypogonadism Associated with Testosterone Deficiency
July 15, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.